Actualités

In the podcast "Woman of the Week" from Bayerischer Rundfunk, Eva van Pelt, Co-CEO & Chief Commercial Officer, spoke with Vanessa Schneider.

Eva talks about the current effects of the Coronavirus and Eppendorf's contribution, but also about her own personal career and formative moments in her professional life. She also gives insights on what helped her in her career. Her personal business tips are not only interesting for women.

The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators.

For 75 years it has been Eppendorf's mission to support its customers in their work as a reliable partner. The current challenges posed by the corona virus are therefore both a mission and a motivation for Eppendorf to provide you with the best possible support even in this extraordinary and difficult situation.

Hamburg/Tokyo, March 19, 2020 – Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research.

From Cell Seeding to Analysis - Getting the Best Out of Your Cell-based Assay

Discover the Digital World of Eppendorf

Eppendorf & Science Prize for Neurobiology 2020

New 25 mL conical tube for improved handling and space saving sample storage.

Improve the reproducibility of your experiments – Liquid Handling is a crucial factor, exemplarily shown for NGS, ELISA and qPCR

The American scientist Lauren Orefice, Ph.D., Assistant Professor at Massachusetts General Hospital and Harvard Medical School has won the 2019 Eppendorf & Science Prize for Neurobiology for her work on the causes and potential therapies for autism spectrum disorders (ASD).